- NPPA asked to revisit decision on prices for insulin: Srikant Kumar Jena
The DoP has asked NPPA to revisit the decision of fixing ceiling prices of various insulin formulations in the wake of review applications ...
02 May, 2013, 06.21 PM IST
Imported Insulin drugs may soon become costlierGovt has given NPPA, a deadline of two months to revise its November order and allow MNCs to raise prices of imported insulin injections.
08 Apr, 2013, 05.00 AM IST
- NPPA’s price ceiling on insulin absurd, will encourage imports: Kiran Mazumdar-Shaw, Biocon
In an interview with ET Now, Kiran Mazumdar-Shaw, CMD, Biocon, talks about NPPA’s price ceiling on insulin and its effects on Biocon.
21 Nov, 2012, 12.01 PM IST
- Biocon, Wockhardt slip on NPPA insulin ceiling order
Shares of Biocon and Wockhardt were witnessing selling pressure after NPPA imposed a blanket ceiling on insulin prices, irrespective of the...
21 Nov, 2012, 10.53 AM IST
- Eli Lilly's imported insulin to cost same after NPPA's margin blow
The drug price regulator has halved the margin available to Eli Lilly on its imported insulin brands, effectively taking the sting out of a...
30 Jul, 2011, 04.25 AM IST
- Eli Lilly insulin brand paves way for hike in imported drug prices
The NPPA will have to increase MRP of US firm Eli Lilly’s insulin brand, paving the way for price increases of other imported medicines who...
11 Jun, 2011, 04.21 AM IST
- Wockhardt, Biocon allowed to raise Insulin prices by 18%
NPPA has slashed the price of anti-asthma bulk drug used in popular brands such as Cipla's Asthalin, by 18% to Rs 3,633 per kg.
17 Mar, 2011, 05.06 AM IST
- NPPA allows hike in insulin price
Indian drug price regulator has allowed local drugmakers such as Biocon and Wockhardt to increase the price of insulin used by diabetes pat...
25 Dec, 2010, 04.37 AM IST
- NPPA revises prices of some more medicines downward
The Central drug price regulator has revised prices of 240 medicines such as antibiotic tablets, multi-vitamin formulations, eye-drops, ins...
17 Sep, 2009, 01.59 AM IST
'Basalog does not come under NPPA purview, NPPA should make the correction'Biocon’s CMD Kiran Mazumdar Shaw is betting big on the oral insulin drug that the company is scheduled to unveil next March. She said the f...
26 Aug, 2009, 09.46 PM IST
- Govt slashes drug prices
The drug price regulator National Pharmaceutical Pricing Authority has revised prices of 887 medicines, including steroids, insulin, vitami...
07 Aug, 2009, 12.19 AM IST
- Insulin prices may come down by 70 per cent
Insulin prices are likely to fall by up to 70 per cent as drug price regulator the National Pharmaceutical Pricing Authority (NPPA) has bro...
06 Aug, 2009, 09.26 PM IST
- Wockhardt, Biocon insulin prices to fall by 70%
Indian copycats of French drug maker Sanofi Aventis’ premium insulin formulation, Lantus, will soon become about 70% cheaper with the count...
04 Aug, 2009, 02.59 AM IST
- Wockhardt, Biocon under NPPA scanner
Wockhardt and Biocon have come under the drug price regulator National Pharmaceutical Pricing Authority (NPPA) scanner for allegedly violat...
29 Jun, 2009, 04.53 AM IST
- Insulin, cancer drugs will cost more soon
Prices of various insulin brands and cancer drugs will soon increase while medicines for asthma, meningitis and diphtheria will become chea...
08 Dec, 2008, 12.30 AM IST
- Home price-peg remedy for costly MNC drugs
Costly imported medicines are under the lens of the drug price regulator.
03 Nov, 2008, 12.11 AM IST
- Changing Prescription: NPPA revises prices of 149 medicines
The NPPA has revised both ceiling and non-ceiling prices of medicines. It is learnt that prices in case of 14 formulation packs have been r...
06 Oct, 2008, 01.33 AM IST